Prevention of delayed ischemic deficits after aneurysmal subarachnoid hemorrhage by intrathecal bolus injection of tissue plasminogen activator

Completed

Phase N/A Results

Summary of Purpose

To examine the efficacy of a single bolus injection of rtPA in the prevention of delayed ischemic deficits after aneurysmal subarachnoid hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 July 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective, non-randomized, controlled trial of 120 patients at a single center.

Contacts

Not available